Dexlansoprazole Completed Phase 4 Trials for Gastro-esophageal Reflux Disease (GERD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02351960Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease